Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kerins

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The American Journal of the Medical Sciences|June 1, 1991
Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infectionD M Kerins
The American Journal of the Medical Sciences|March 1, 1994
Role of the perfluorocarbon Fluosol-DA in coronary angioplastyD M Kerins
Drugs|May 1, 1991
The current role of platelet-active drugs in ischaemic heart diseaseD M Kerins, G A FitzGerald
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology|May 21, 1999
Comparison of the half-lives and regeneration rates of blood clotting factors II, VII, and X in anticoagulant-resistant and susceptible Norway rats (Rattus norvegicus Berk.)G M Kerins, A D MacNicoll
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 30, 2005
Tetanus and intravenous drug useA Barsam, M Kerins, P Jaye
Clinical Anatomy (New York, N.Y.)|March 6, 2002
Posterior dislocation of the sternoclavicular joint: a case report and review of the clinical anatomy of the regionS Rajaratnam, M Kerins, L Apthorp
Emergency Medicine Journal : EMJ|November 22, 2005
Cardiac luxation: an unusual complication of a log rollM Kerins, E Maguire, C Lacy
Emergency Medicine Journal : EMJ|September 29, 2005
Prehospital activated charcoal: the way forwardS L Greene, M Kerins, N O'Connor
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardiovascular safety of anti-diabetic drugsR Kumar, D M Kerins, T Walther
FEBS Letters|April 12, 2003
Characterisation of Archaeglobus fulgidus AlkA hypoxanthine DNA glycosylase activityColin Mansfield, Sinéad M Kerins, Tommie V McCarthy
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The American Journal of the Medical Sciences|June 1, 1991
Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infectionD M Kerins
The American Journal of the Medical Sciences|March 1, 1994
Role of the perfluorocarbon Fluosol-DA in coronary angioplastyD M Kerins
Drugs|May 1, 1991
The current role of platelet-active drugs in ischaemic heart diseaseD M Kerins, G A FitzGerald
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology|May 21, 1999
Comparison of the half-lives and regeneration rates of blood clotting factors II, VII, and X in anticoagulant-resistant and susceptible Norway rats (Rattus norvegicus Berk.)G M Kerins, A D MacNicoll
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 30, 2005
Tetanus and intravenous drug useA Barsam, M Kerins, P Jaye
Clinical Anatomy (New York, N.Y.)|March 6, 2002
Posterior dislocation of the sternoclavicular joint: a case report and review of the clinical anatomy of the regionS Rajaratnam, M Kerins, L Apthorp
Emergency Medicine Journal : EMJ|November 22, 2005
Cardiac luxation: an unusual complication of a log rollM Kerins, E Maguire, C Lacy
Emergency Medicine Journal : EMJ|September 29, 2005
Prehospital activated charcoal: the way forwardS L Greene, M Kerins, N O'Connor
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardiovascular safety of anti-diabetic drugsR Kumar, D M Kerins, T Walther
FEBS Letters|April 12, 2003
Characterisation of Archaeglobus fulgidus AlkA hypoxanthine DNA glycosylase activityColin Mansfield, Sinéad M Kerins, Tommie V McCarthy
Pageof 5